Clinical Trials Browser

Has results × Oxaliplatin × 1 year × Clear all

Colonic Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Stomach Neoplasms

Metastatic Adenocarcinoma of the Pancreas

Pancreatic Neoplasms

Lymphoma, Non-Hodgkin

Colorectal Adenocarcinoma

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Gallbladder Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

Stomach Neoplasms

Neoplasm Metastasis, Neoplasms

Adenocarcinoma, Neoplasms, Stomach Neoplasms

Adenocarcinoma, Neoplasms, Stomach Neoplasms

Stomach Neoplasms

Lymphoma, Lymphoma, Large B-Cell, Diffuse

Rectal Neoplasms

Rectal Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms

Pancreatic Adenocarcinoma

Esophageal Neoplasms, Stomach Neoplasms

CNS Germ Cell Tumor

Adenocarcinoma, Neoplasms, Stomach Neoplasms

Colorectal Neoplasms

Colonic Neoplasms, Peritoneal Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Locally Advanced and Metastatic Solid Tumors

Esophageal Neoplasms, Neoplasm Metastasis, Neoplasms

Adenocarcinoma Of Esophagus, Stomach Neoplasms

Esophageal Squamous Cell Carcinoma

Stomach Neoplasms

Lymphoma, Non-Hodgkin

Colonic Neoplasms

Colonic Neoplasms, Colorectal Neoplasms

Adenocarcinoma, Gastrointestinal Neoplasms, Neoplasm Metastasis

Clinical Trials

Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer

KEYNOTE-585

NAPOLI 3

Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer

SUNMO

SOLARIS

Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers

TOGAR

METIMMOX

Spotlight

GLOW

A Study of Atezolizumab and Trastuzumab in Combination With Capecitabine and Oxaliplatin in Patients With HER2 Positive Locally Advanced Resectable Gastric Cancer of Adenocarcinoma of Gastroesophageal Junction

POLARGO

SHORT

Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer

Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer

A Study of Multiple Immunotherapy-Based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer)

CAPOX, Bevacizumab and Trastuzumab for Patients With HER2-Positive Metastatic Esophagogastric Cancer

Gemcitabine, Paclitaxel and Oxaliplatin (GemPOx)

DisTinGuish

CheckMate 8HW

COCHISE

Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors

LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib

CheckMate649

A Study of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma

Pembrolizumab, Combination Chemotherapy, and Radiation Therapy Before Surgery in Treating Adult Patients With Locally Advanced Gastroesophageal Junction or Gastric Cardia Cancer That Can Be Removed by Surgery

Trial of Magrolimab (Hu5F9-G4) in Combination With Rituximab or Rituximab + Chemotherapy in Participants With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer Treatment

A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric Cancer